Last update :
28/04/2024
References   References 1970  
Type : Journal

Research teams : Madrid - Universidad Complutense de Madrid,Facultad de Farmacia
Authors : Barcia E, Reyes R, Azuara M.L, S?nchez Y, Negro S.
Title : Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care.
Reference : Support Care Cancer ; 11, 2: 107-113. 2003

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionHaloperidol lactate Neuroleptic
Compatible 0,3125 >> 1,25 mg/ml + InjectionScopolamine N-butyl bromide 2,5 >> 10 mg/ml + Sodium chloride 0,9%
InjectionScopolamine N-butyl bromide Antimuscarinic
Compatible 2,5 >> 10 mg/ml + InjectionHaloperidol lactate 0,3125 >> 1,25 mg/ml + Sodium chloride 0,9%
Stability of mixtures
Polypropylene Sodium chloride 0,9% 4°C Protect from light
Injection Scopolamine N-butyl bromide 2,5 & 5 & 10 mg/ml
Injection Haloperidol lactate 0,312 mg/ml
15 Day

  Mentions Légales